Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026)
Harmony Biosciences Holdings' EBT Margin was 35.70% in Q2 2026, up 10.94 percentage points from 24.76% a year earlier and up 17.27 percentage points from the prior quarter.
Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harmony Biosciences Holdings' EBT Margin was 25.13% through Jun 30, 2026, down 4.02 percentage points year-over-year; for FY2025, it was 24.76%, down 2.07 percentage points from FY2024.
- EBT Margin shows a five-year change of +47.89 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 26.84% in FY2024 (-2.96 pp), 29.79% in FY2023 (+5.88 pp), 23.91% in FY2022 (+11.66 pp) and 12.25% in FY2021 (+35.38 pp).
- The Q2 2026 figure marks the highest quarterly EBT Margin in data going back to Q1 2020.
- Compared with a year earlier, EBT Margin was higher in four of the last eight quarters, with an average year-over-year change of -0.37 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q4 2021 (a gain of 27.20 percentage points); the worst was Q2 2024 (a drop of 20.30 percentage points).
- Per Business Quant data, HRMY's EBT Margin in the three quarters before Q2 2026 was 18.43% (Q1 2026), 16.72% (Q4 2025) and 28.18% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -4.34% |
| 10 | Harmony Biosciences Holdings | 2.25 Bn | -506.77 Mn | 198.08 Mn | 35.70% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.70% |
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 28.18% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 30.95% |
| Dec 31, 2024 | 27.90% |
| Sep 30, 2024 | 33.42% |
| Jun 30, 2024 | 12.55% |
| Mar 31, 2024 | 33.49% |
| Dec 31, 2023 | 23.57% |
| Sep 30, 2023 | 32.34% |
| Jun 30, 2023 | 32.85% |
| Mar 31, 2023 | 31.71% |
| Dec 31, 2022 | 34.37% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 27.31% |
| Mar 31, 2022 | 27.41% |
| Dec 31, 2021 | 26.83% |
| Sep 30, 2021 | -13.03% |
Harmony Biosciences Holdings EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();